纳米药物向髓衍生的抑制细胞增强抗瘤免疫力

相关实验视频

Updated: Jul 4, 2025

Preparation of Myeloid Derived Suppressor Cells MDSC from Naive and Pancreatic Tumor-bearing Mice using Flow Cytometry and Automated Magnetic Activated Cell Sorting AutoMACS

Preparation of Myeloid Derived Suppressor Cells MDSC from Naive and Pancreatic Tumor-bearing Mice using Flow Cytometry and Automated Magnetic Activated Cell Sorting AutoMACS

Published on: June 18, 2012

En-Li Yang¹, Zhi-Jun Sun¹

¹State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Frontier Science Center for Immunology and Metabolism, Wuhan University, Wuhan, Hubei, 430079, China.

Advanced healthcare materials

|January 30, 2024

概括

用纳米药物准髓质衍生抑制细胞 (MDSC) 可以克服癌症免疫疗法抵抗力. 这种方法修改了瘤微环境 (TME),以增强抗瘤免疫反应并提高治疗疗效.

科学领域:

免疫学免疫学免疫学
纳米医学是一种纳米医学.
在瘤学瘤学.

背景情况:

癌症免疫疗法面临着挑战,因为反应率低于最佳.
瘤微环境 (TME) 中的骨髓菌原抑制细胞 (MDSC) 促进免疫抑制,阻碍抗癌免疫力.
准MDSC对于提高免疫疗法的有效性至关重要.

研究的目的:

审查MDSC在TME和当前目标策略中的作用.
突出纳米医学的好处,用于MDSC向药物输送.
总结纳米医学在增强癌症免疫疗法的进展.

主要方法:

对MDSCs,TME和纳米医学现有文献的审查.
分析纳米粒子辅助药物递送系统的MDSC向.
综合当前关于纳米医学对治疗疗效和安全影响的研究.

主要成果:

纳米药物提供了设计灵活性,高效的药物加载,以及对MDSC向的降解保护.
用纳米药物向MDSC可以提高治疗疗效和提高安全性.
纳米医学调节TME,将免疫抑制瘤转化为更有反应力的环境.

结论:

针对MDSCs的基于纳米医学的策略在推进癌症免疫治疗方面具有重大前景.
纳米医学的进一步发展可以导致更强大,更有效的抗癌治疗.
通过MDSC向调节TME是克服免疫疗法耐药性的关键策略.

关键词:

癌症免疫疗法免疫疗法骨髓蛋白衍生的抑制细胞.纳米药物是一种纳米药物.有针对性的治疗.瘤微环境是一个微环境.

更多相关视频

Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells

Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells

Published on: January 29, 2019

Isolation and Characterization of Neutrophils with Anti-Tumor Properties

Isolation and Characterization of Neutrophils with Anti-Tumor Properties

Published on: June 19, 2015

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...